Back to BlackRock, Inc. BlackRock, Inc.

ZNTLZNTL
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ZENTALIS PHARMACEUTICALS INC

BlackRock, Inc. holds 3.8M shares of ZNTL (ZENTALIS PHARMACEUTICALS INC), worth $18.2M as of 2026-Q2. The position was increased (+195.6% shares). ZNTL represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$18.2M

Current Shares

3.8M

Total Value Change

+$5.4M

Total Shares Change

-484,564

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.8M
+195.6%
$18.2M0.0%$4.85
46
2026-Q1
Increased
1.3M
+1.6%
$3M0.0%$2.38
27
2025-Q4
Increased
1.2M
+0.0%
$1.7M0.0%$1.33
17
2025-Q3
Decreased
1.2M
-28.3%
$1.9M0.0%$1.49
0
2025-Q2
Decreased
1.7M
-58.8%
$2M0.0%$1.18
0
2025-Q1
Decreased
4.2M
-0.2%
$6.7M0.0%$1.81
0
2024-Q4
New
4.2M
-
$12.8M0.0%$2.92
39

Other major holders of ZNTL: VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used